Endometrial cancer and genetic variation in PTEN, PIK3CA, AKT1, MLH1, and MSH2 within a population-based case-control study

Gynecologic Oncology

Volumn 120, Issue 2, 2011, Pages 167-173

  Lacey Jr , James V ^a,g   Yang, Hannah ^a   Gaudet, Mia M ^a,b   Dunning, Alison ^c   Lissowska, Jolanta ^a,d   Sherman, Mark E ^a   Peplonska, Beata ^a,e   Brinton, Louise A ^a   Healey, Catherine S ^c   Ahmed, Shahana ^c   Pharoah, Paul ^c   Easton, Douglas ^c   Chanock, Stephen ^a,f   Garcia Closas, Montserrat ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d INSTITUTE OF ONCOLOGY   (Poland)

^e NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Epidemiology; Haplotypes; SNPs; Uterine cancer

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE 3CA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHATIDYLINOSITOL 4 PHOSPHATE KINASE; PROTEIN AKT1; PROTEIN KINASE B; PROTEIN MLH1; PROTEIN MSH2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RISK; DNA FLANKING REGION; ENDOMETRIUM CANCER; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLAND; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; CASE-CONTROL STUDIES; ENDOMETRIAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS; PHOSPHATIDYLINOSITOL 3-KINASES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; YOUNG ADULT;

EID: 79251600170     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.10.016     Document Type: Article

References (32)

1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and T. Murray Cancer statistics CA Cancer J Clin 58 2008 71 96
2. D.M. Purdie, and A.C. Green Epidemiology of endometrial cancer Best Pract Res Clin Obstet Gynaecol 15 2001 341 354
3. V. Stambolic, M.S. Tsao, D. Macpherson, A. Suzuki, W.B. Chapman, and T.W. Mak High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice Cancer Res 60 2000 3605 3611
4. H. Wang, W. Douglas, M. Lia, W. Edelmann, R. Kucherlapati, and K. Podsypanina DNA mismatch repair deficiency accelerates endometrial tumorigenesis in Pten heterozygous mice Am J Pathol 160 2002 1481 1486
5. D.J. Marsh, P.L. Dahia, S. Caron, J.B. Kum, I.M. Frayling, and I.P. Tomlinson Germline PTEN mutations in Cowden syndrome-like families J Med Genet 35 1998 881 885
6. X.P. Zhou, D.J. Marsh, C.D. Morrison, A.R. Chaudhury, M. Maxwell, and G. Reifenberger Germline inactivation of PTEN and dysregulation of the phosphoinositol-3-kinase/Akt pathway cause human Lhermitte-Duclos disease in adults Am J Hum Genet 73 2003 1191 1198
7. L.H. Saal, P. Johansson, K. Holm, S.K. Gruvberger-Saal, Q.B. She, and M. Maurer Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity Proc Natl Acad Sci USA 104 2007 7564 7569
8. C. Blanco-Aparicio, O. Renner, J.F. Leal, and A. Carnero PTEN, more than the AKT pathway Carcinogenesis 28 2007 1379 1386
9. I.G. Campbell, S.E. Russell, D.Y. Choong, K.G. Montgomery, M.L. Ciavarella, and C.S. Hooi Mutation of the PIK3CA gene in ovarian and breast cancer Cancer Res 64 2004 7678 7681
10. D.A. Levine, F. Bogomolniy, C.J. Yee, A. Lash, R.R. Barakat, and P.I. Borgen Frequent mutation of the PIK3CA gene in ovarian and breast cancers Clin Cancer Res 11 2005 2875 2878
11. K. Stemke-Hale, A.M. Gonzalez-Angulo, A. Lluch, R.M. Neve, W.L. Kuo, and M. Davies An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer Cancer Res 68 2008 6084 6091
12. M.P. Hayes, H. Wang, R. Espinal-Witter, W. Douglas, G.J. Solomon, and S.J. Baker PIK3CA and PTEN mutations in uterine endometrioid carcinoma and complex atypical hyperplasia Clin Cancer Res 12 2006 5932 5935
13. K. Oda, D. Stokoe, Y. Taketani, and F. McCormick High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma Cancer Res 65 2005 10669 10673
14. V.E. Velculescu Defining the blueprint of the cancer genome Carcinogenesis 29 2008 1087 1091
15. Y. Samuels, Z. Wang, A. Bardelli, N. Silliman, J. Ptak, and S. Szabo High frequency of mutations of the PIK3CA gene in human cancers Science 304 2004 554
16. K.H. Lu, J.O. Schorge, K.J. Rodabaugh, M.S. Daniels, C.C. Sun, and P.T. Soliman Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer J Clin Oncol 25 2007 5158 5164
17. K. Imai, and H. Yamamoto Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics Carcinogenesis 29 2008 673 680
18. S.H. Olson, E.V. Bandera, and I. Orlow Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: a HuGE review Am J Epidemiol 165 2007 235 245
19. V.W. Setiawan, J.A. Doherty, X.O. Shu, M.R. Akbari, C. Chen, and I. De Vivo Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium Cancer Epidemiol Biomark Prev 18 2009 242 247
20. L.A. Brinton, L.C. Sakoda, J. Lissowska, M.E. Sherman, N. Chatterjee, and B. Peplonska Reproductive risk factors for endometrial cancer among Polish women Br J Cancer 96 2007 1450 1456
21. M.M. Gaudet, J.V. Lacey Jr., J. Lissowska, B. Peplonska, L.A. Brinton, and S. Chanock Genetic variation in CYP17 and endometrial cancer risk Hum Genet 123 2008 155 162
22. Z. Yu, and D.J. Schaid Sequential haplotype scan methods for association analysis Genet Epidemiol 31 2007 553 564
23. K. Yu, Q. Li, A.W. Bergen, R.M. Pfeiffer, P.S. Rosenberg, and N. Caporaso Pathway analysis by adaptive combination of P-values Genet Epidemiol 33 2009 700 709
24. H.P. Yang, J. Gonzalez Bosquet, Q. Li, E.A. Platz, L.A. Brinton, and M.E. Sherman Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes Carcinogenesis 31 2010 827 833
25. D.J. Balding A tutorial on statistical methods for population association studies Nat Rev Genet 7 2006 781 791
26. J.I. Risinger, A.K. Hayes, A. Berchuck, and J.C. Barrett PTEN/MMAC1 mutations in endometrial cancers Cancer Res 57 1997 4736 4738
27. C. Eng PTEN: one gene, many syndromes Hum Mutat 22 2003 183 198
28. C.A. Haiman, D.O. Stram, I. Cheng, E.E. Giorgi, L. Pooler, and K. Penney Common genetic variation at PTEN and risk of sporadic breast and prostate cancer Cancer Epidemiol Biomark Prev 15 2006 1021 1025
29. M. Ollikainen, A. Gylling, M. Puputti, N.N. Nupponen, W.M. Abdel-Rahman, and R. Butzow Patterns of PIK3CA alterations in familial colorectal and endometrial carcinoma Int J Cancer 121 2007 915 920
30. T. Wang, G. Ho, K. Ye, H. Strickler, and R.C. Elston A partial least-square approach for modeling gene-gene and gene-environment interactions when multiple markers are genotyped Genet Epidemiol 33 2009 6 15
31. M.E. Beiner, B. Rosen, A. Fyles, I. Harley, T. Pal, and K. Siminovitch Endometrial cancer risk is associated with variants of the mismatch repair genes MLH1 and MSH2 Cancer Epidemiol Biomark Prev 15 2006 1636 1640
32. N.S. Weiss Subgroup-specific associations in the face of overall null results: should we rush in or fear to tread? Cancer Epidemiol Biomark Prev 17 2008 1297 1299